ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CERO Company Profile and Key Details

NASDAQ : CERO

CERo Therapeutics Holdings, Inc.

$0.77

-0.066-7.89%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

CERO Stock Price Chart

Stock Price Today

CERo Therapeutics Holdings, Inc. (CERO) stock declined over -7.89%, trading at $0.77 on NASDAQ, down from the previous close of $0.84. The stock opened at $0.81, fluctuating between $0.77 and $0.81 in the recent session.

Stock Snapshot

0.836

Prev. Close

0.81

Open

2.33M

Market Cap

3.03M

Number of Shares

0.77

Day Low

0.809

Day High

-0.01

P/E Ratio

80.39%

Free Float in %

-118.56

EPS (TTM)

N/A

Book Value

N/A

Cash Flow per Share

491.82K

Volume

Relevant Articles

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 10, 2025	0.81	0.82	0.75	0.77	494K
Apr 09, 2025	0.72	0.84	0.68	0.84	485.79K
Apr 08, 2025	0.72	0.79	0.69	0.71	317.71K
Apr 07, 2025	0.67	0.72	0.67	0.71	237.4K
Apr 04, 2025	0.68	0.89	0.68	0.72	2.04M
Apr 03, 2025	0.71	0.72	0.67	0.70	184.06K
Apr 02, 2025	0.68	0.75	0.68	0.73	181.07K
Apr 01, 2025	0.69	0.78	0.65	0.72	317.91K
Mar 31, 2025	0.73	0.80	0.67	0.73	6.47M
Mar 28, 2025	0.74	0.76	0.71	0.75	193.44K
Mar 27, 2025	0.74	0.83	0.66	0.77	5.35M
Mar 26, 2025	0.88	0.95	0.83	0.85	123.02K
Mar 25, 2025	0.92	1.03	0.86	0.89	343.74K
Mar 24, 2025	0.93	1.03	0.90	0.95	439.5K
Mar 21, 2025	0.94	0.94	0.90	0.91	61.98K
Mar 20, 2025	0.93	0.98	0.87	0.96	138.84K
Mar 19, 2025	0.89	0.93	0.89	0.93	68.3K
Mar 18, 2025	0.90	0.93	0.82	0.91	186.32K
Mar 17, 2025	0.99	1.02	0.90	0.93	238.11K
Mar 14, 2025	0.95	1.03	0.94	1.02	258.6K

Contact Details

South San Francisco, CA 94080

United States

Website: https://www.cero.bioContact: 650 407 2376

About Company

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Frequently Asked Questions

What is the current CERo Therapeutics Holdings, Inc. (CERO) stock price?

CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) stock price is $0.77 in the last trading session. During the trading session, CERO stock reached the peak price of $0.81 while $0.77 was the lowest point it dropped to. The percentage change in CERO stock occurred in the recent session was -7.89% while the dollar amount for the price change in CERO stock was -$0.07.

CERO's industry and sector of operation?

The NASDAQ listed CERO is part of Biotechnology industry that operates in the broader Healthcare sector. CERo Therapeutics Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CERO?

No Data

How CERO did perform over past 52-week?

CERO's closing price is 18.46% higher than its 52-week low of $0.65 where as its distance from 52-week high of $196.00 is -99.61%.

How many employees does CERO have?

Number of CERO employees currently stands at 8.

Link for CERO official website?

Official Website of CERO is: https://www.cero.bio

How do I contact CERO?

CERO could be contacted at phone 650 407 2376 and can also be accessed through its website. CERO operates from 201 Haskins Way, South San Francisco, CA 94080, United States.

How many shares of CERO are traded daily?

CERO stock volume for the day was 491.82K shares. The average number of CERO shares traded daily for last 3 months was 704.26K.

What is the market cap of CERO currently?

The market value of CERO currently stands at $2.33M with its latest stock price at $0.77 and 3.03M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	8
Beta	0.43
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology